Loading…
Reported covered position: Legislative Director, Deputy Chief of Staff and Chief of Staff, Congressman Bob Latta (OH-5)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Mental and Physical Health Care Comorbidities Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025.
Mental and Physical Health Care Comorbidities Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2026 · third_quarter · Q3
H.R. 5256, the 340B ACCESS Act.
FY 2027 National Defense Authorization Act.
Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025; H.R. 8375/S. 4384, Medicare Advantage Improvement Act of 2026.
Source: Senate LDA
Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025; H.R. 8375/S. 4384, Medicare Advantage Improvement Act of 2026.
Mental and Physical Health Care Comorbidities Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025; H.R. 8375/S. 4384, Medicare Advantage Improvement Act of 2026.
Health Care PRICE Transparency Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025; H.R. 8375/S. 4384, Medicare Advantage Improvement Act of 2026.
Health Care PRICE Transparency Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025.
Health Care PRICE Transparency Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025; H.R. 8375/S. 4384, Medicare Advantage Improvement Act of 2026.
Health Care PRICE Transparency Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B modernization; impact of regional oversaturation of trauma care on patient outcomes and health system costs; Pandemic and All Hazards Preparedness Act reauthorization; H.R. 267, the Health care PRICE Transparency Act; H.R. 5256, the 340B ACCESS Act; H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025; H.R. 7279/S. 3707, Nurse Faculty Shortage Reduction Act of 2026.
Health Care PRICE Transparency Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B modernization; impact of regional oversaturation of trauma care on patient outcomes and health system costs; Pandemic and All Hazards Preparedness Act reauthorization; H.R. 267, the Health care PRICE Transparency Act; H.R. 5256, the 340B ACCESS Act; H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
Health Care PRICE Transparency Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B modernization; impact of regional oversaturation of trauma care on patient outcomes and health system costs; Pandemic and All Hazards Preparedness Act reauthorization; H.R. 267, the Health care PRICE Transparency Act; H.R. 5256, the 340B ACCESS Act; H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025; H.R. 7279/S. 3707, Nurse Faculty Shortage Reduction Act of 2026.
Hospital Inpatient Services Modernization Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025.
Hospital Inpatient Services Modernization Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025; H.R. 8375/S. 4384, Medicare Advantage Improvement Act of 2026.
Hospital Inpatient Services Modernization Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025; H.R. 8375/S. 4384, Medicare Advantage Improvement Act of 2026.
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B modernization; impact of regional oversaturation of trauma care on patient outcomes and health system costs; Pandemic and All Hazards Preparedness Act reauthorization; H.R. 267, the Health care PRICE Transparency Act; H.R. 5256, the 340B ACCESS Act; H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025; H.R. 7279/S. 3707, Nurse Faculty Shortage Reduction Act of 2026.
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B modernization; impact of regional oversaturation of trauma care on patient outcomes and health system costs; Pandemic and All Hazards Preparedness Act reauthorization; H.R. 267, the Health care PRICE Transparency Act; H.R. 5256, the 340B ACCESS Act; H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B modernization; impact of regional oversaturation of trauma care on patient outcomes and health system costs; Pandemic and All Hazards Preparedness Act reauthorization; H.R. 267, the Health care PRICE Transparency Act; H.R. 5256, the 340B ACCESS Act; H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025; H.R. 7279/S. 3707, Nurse Faculty Shortage Reduction Act of 2026.
H.R. 5256, the 340B ACCESS Act.
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B modernization; impact of regional oversaturation of trauma care on patient outcomes and health system costs; Pandemic and All Hazards Preparedness Act reauthorization; H.R. 267, the Health care PRICE Transparency Act; H.R. 5256, the 340B ACCESS Act; H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
H.R. 5256, the 340B ACCESS Act.
H.R. 5256, the 340B ACCESS Act.
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B modernization; impact of regional oversaturation of trauma care on patient outcomes and health system costs; Pandemic and All Hazards Preparedness Act reauthorization; H.R. 267, the Health care PRICE Transparency Act; H.R. 5256, the 340B ACCESS Act; H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025; H.R. 7279/S. 3707, Nurse Faculty Shortage Reduction Act of 2026.
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B modernization; impact of regional oversaturation of trauma care on patient outcomes and health system costs; Pandemic and All Hazards Preparedness Act reauthorization; H.R. 267, the Health care PRICE Transparency Act; H.R. 5256, the 340B ACCESS Act; H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025; H.R. 7279/S. 3707, Nurse Faculty Shortage Reduction Act of 2026.
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Funding for drug therapeutic infusion pumps; H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Funding for drug therapeutic infusion pumps; H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Funding for drug therapeutic infusion pumps; H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.
Nurse Faculty Shortage Reduction Act of 2026
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B modernization; impact of regional oversaturation of trauma care on patient outcomes and health system costs; Pandemic and All Hazards Preparedness Act reauthorization; H.R. 267, the Health care PRICE Transparency Act; H.R. 5256, the 340B ACCESS Act; H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025; H.R. 7279/S. 3707, Nurse Faculty Shortage Reduction Act of 2026.
Nurse Faculty Shortage Reduction Act of 2026
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B modernization; impact of regional oversaturation of trauma care on patient outcomes and health system costs; Pandemic and All Hazards Preparedness Act reauthorization; H.R. 267, the Health care PRICE Transparency Act; H.R. 5256, the 340B ACCESS Act; H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025; H.R. 7279/S. 3707, Nurse Faculty Shortage Reduction Act of 2026.
Medicare Advantage Improvement Act of 2026
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025; H.R. 8375/S. 4384, Medicare Advantage Improvement Act of 2026.
Medicare Advantage Improvement Act of 2026
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025; H.R. 8375/S. 4384, Medicare Advantage Improvement Act of 2026.
Mental and Physical Health Care Comorbidities Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025; H.R. 8375/S. 4384, Medicare Advantage Improvement Act of 2026.
Mental and Physical Health Care Comorbidities Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025.
Mental and Physical Health Care Comorbidities Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025; H.R. 8375/S. 4384, Medicare Advantage Improvement Act of 2026.
Hospital Inpatient Services Modernization Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025; H.R. 8375/S. 4384, Medicare Advantage Improvement Act of 2026.
Hospital Inpatient Services Modernization Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025.
Hospital Inpatient Services Modernization Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025; H.R. 8375/S. 4384, Medicare Advantage Improvement Act of 2026.
Nurse Faculty Shortage Reduction Act of 2026
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B modernization; impact of regional oversaturation of trauma care on patient outcomes and health system costs; Pandemic and All Hazards Preparedness Act reauthorization; H.R. 267, the Health care PRICE Transparency Act; H.R. 5256, the 340B ACCESS Act; H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025; H.R. 7279/S. 3707, Nurse Faculty Shortage Reduction Act of 2026.
Nurse Faculty Shortage Reduction Act of 2026
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B modernization; impact of regional oversaturation of trauma care on patient outcomes and health system costs; Pandemic and All Hazards Preparedness Act reauthorization; H.R. 267, the Health care PRICE Transparency Act; H.R. 5256, the 340B ACCESS Act; H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025; H.R. 7279/S. 3707, Nurse Faculty Shortage Reduction Act of 2026.
Medicare Advantage Improvement Act of 2026
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025; H.R. 8375/S. 4384, Medicare Advantage Improvement Act of 2026.
Medicare Advantage Improvement Act of 2026
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025; H.R. 8375/S. 4384, Medicare Advantage Improvement Act of 2026.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 1, the One Big Beautiful Bill Act; and H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Funding for the HUD HOME program; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; and H.R. 1, the One Big Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 1, the One Big Beautiful Bill Act; and H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 1, the One Big Beautiful Bill Act; and H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 1, the One Big Beautiful Bill Act; and H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Funding for the HUD HOME program; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; and H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Funding for the HUD HOME program; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; and H.R. 1, the One Big Beautiful Bill Act.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 1, the One Big Beautiful Bill Act; and H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 1, the One Big Beautiful Bill Act; and H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies, including for audio-only telehealth services; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
Funding for the HUD HOME program; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; and H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025.
Medicaid State Directed Payments; 340B Modernization; Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; H.R. 10337, Expanding the Health Care Workforce Act; and H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 1, the One Big Beautiful Bill Act; and H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.
Medicaid State Directed Payments; 340B Modernization; Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
Funding for the HUD HOME program; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; and H.R. 1, the One Big Beautiful Bill Act.
H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 1, the One Big Beautiful Bill Act; and H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.
Medicaid State Directed Payments; 340B Modernization; Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 1, the One Big Beautiful Bill Act; and H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; H.R. 10337, Expanding the Health Care Workforce Act; and H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies, including for audio-only telehealth services; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8247, the Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; and H.R. 10337, Expanding the Health Care Workforce Act.
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; H.R. 10337, Expanding the Health Care Workforce Act; and H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8247, the Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; and H.R. 10337, Expanding the Health Care Workforce Act.
National Museum of Pop Culture Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B Modernization; Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
National Museum of Pop Culture Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; H.R. 10337, Expanding the Health Care Workforce Act; and H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
National Museum of Pop Culture Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B Modernization; Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
National Museum of Pop Culture Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8247, the Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; and H.R. 10337, Expanding the Health Care Workforce Act.
National Museum of Pop Culture Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; H.R. 10337, Expanding the Health Care Workforce Act; and H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
National Museum of Pop Culture Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies, including for audio-only telehealth services; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
National Museum of Pop Culture Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies, including for audio-only telehealth services; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
National Museum of Pop Culture Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; H.R. 10337, Expanding the Health Care Workforce Act; and H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
National Museum of Pop Culture Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B Modernization; Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
National Museum of Pop Culture Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8247, the Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; and H.R. 10337, Expanding the Health Care Workforce Act.
U.S. Diplomatic Posture Review Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; H.R. 10337, Expanding the Health Care Workforce Act; and H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
U.S. Diplomatic Posture Review Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8247, the Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; and H.R. 10337, Expanding the Health Care Workforce Act.
U.S. Diplomatic Posture Review Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; H.R. 10337, Expanding the Health Care Workforce Act; and H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
U.S. Diplomatic Posture Review Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; H.R. 10337, Expanding the Health Care Workforce Act; and H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
U.S. Diplomatic Posture Review Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8247, the Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; and H.R. 10337, Expanding the Health Care Workforce Act.
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; H.R. 10337, Expanding the Health Care Workforce Act; and H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; H.R. 10337, Expanding the Health Care Workforce Act; and H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; H.R. 10337, Expanding the Health Care Workforce Act; and H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 1, the One Big Beautiful Bill Act; and H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 1, the One Big Beautiful Bill Act; and H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 1, the One Big Beautiful Bill Act; and H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.
Preemption of Real Property Discrimination Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B Modernization; Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
Preemption of Real Property Discrimination Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B Modernization; Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
Preemption of Real Property Discrimination Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies, including for audio-only telehealth services; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
Preemption of Real Property Discrimination Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Medicaid State Directed Payments; 340B Modernization; Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
Preemption of Real Property Discrimination Act
Client: THE METROHEALTH SYSTEM · Firm: THE METROHEALTH SYSTEM
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies, including for audio-only telehealth services; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act.
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8247, the Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; and H.R. 10337, Expanding the Health Care Workforce Act.
H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act.
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8247, the Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; and H.R. 10337, Expanding the Health Care Workforce Act.
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; H.R. 10337, Expanding the Health Care Workforce Act; and H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; H.R. 10337, Expanding the Health Care Workforce Act; and H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act.
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; H.R. 10337, Expanding the Health Care Workforce Act; and H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act.
H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act.
Medicaid State Directed Payments; 340B Modernization; Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
Medicaid State Directed Payments; 340B Modernization; Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B modernization; impact of regional oversaturation of trauma care on patient outcomes and health system costs; Pandemic and All Hazards Preparedness Act reauthorization; H.R. 267, the Health care PRICE Transparency Act; H.R. 5256, the 340B ACCESS Act; H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025; H.R. 7279/S. 3707, Nurse Faculty Shortage Reduction Act of 2026.
Funding for drug therapeutic infusion pumps; H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2026 · second_quarter · Q2
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B modernization; impact of regional oversaturation of trauma care on patient outcomes and health system costs; Pandemic and All Hazards Preparedness Act reauthorization; H.R. 267, the Health care PRICE Transparency Act; H.R. 5256, the 340B ACCESS Act; H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025; H.R. 7279/S. 3707, Nurse Faculty Shortage Reduction Act of 2026.
Funding for drug therapeutic infusion pumps; H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.
H.R. 5256, the 340B ACCESS Act.
Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025; H.R. 8375/S. 4384, Medicare Advantage Improvement Act of 2026.
FY 2027 National Defense Authorization Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2026 · first_quarter · Q1
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B modernization; impact of regional oversaturation of trauma care on patient outcomes and health system costs; Pandemic and All Hazards Preparedness Act reauthorization; H.R. 267, the Health care PRICE Transparency Act; H.R. 5256, the 340B ACCESS Act; H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
Funding for drug therapeutic infusion pumps; H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.
FY 2027 National Defense Authorization Act.
H.R. 5256, the 340B ACCESS Act.
Medicaid State Directed Payments; 340B modernization; funding for Disproportionate Share Hospitals (Medicaid DSH); funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; impact of regional oversaturation of trauma care on patient outcomes and health system costs; H.R. 4313/S. 2237, Hospital Inpatient Services Modernization Act; H.R. 267, the Health Care Price Transparency Act; H.R. 2590/S. 1264, the Mental and Physical Health Care Comorbidities Act of 2025.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2025 · fourth_quarter · 4A
H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act.
Medicaid State Directed Payments; 340B Modernization; Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; H.R. 10337, Expanding the Health Care Workforce Act; and H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 1, the One Big Beautiful Bill Act; and H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2025 · fourth_quarter · Q4
Medicaid State Directed Payments; 340B Modernization; Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; H.R. 10337, Expanding the Health Care Workforce Act; and H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 1, the One Big Beautiful Bill Act; and H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.
H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2025 · third_quarter · Q3
Medicaid State Directed Payments; 340B Modernization; Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2025 · second_quarter · Q2
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies, including for audio-only telehealth services; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2025 · first_quarter · Q1
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies, including for audio-only telehealth services; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2024 · fourth_quarter · 4A
H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act.
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8247, the Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; and H.R. 10337, Expanding the Health Care Workforce Act.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2024 · fourth_quarter · Q4
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8247, the Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; and H.R. 10337, Expanding the Health Care Workforce Act.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2024 · third_quarter · Q3
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8247, the Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024; and H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2024 · second_quarter · Q2
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8247, the Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024; and H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2024 · first_quarter · Q1
Funding for the HUD HOME program; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024 and H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024.
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024 and H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2023 · fourth_quarter · Q4
Funding for the HUD HOME program; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; and H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024.
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; COVID-19 regulatory changes in general; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-10 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; support of telehealth policies, including for audio-only telehealth services; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; and H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2023 · third_quarter · Q3
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; and H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; support of telehealth policies, including for audio-only telehealth services; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; and H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act.
Funding for the HUD HOME program; and H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2023 · second_quarter · Q2
Funding for the HUD HOME program; H.R. 2617, the Consolidated Appropriations Act of 2023; and congressionally directed spending request in the HHS Appropriations bill for capital funding for behavioral health facility.
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; and H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; support of telehealth policies, including for audio-only telehealth services; 340B Protect Act, H.R. 4390; H.R. 2617, the Consolidated Appropriations Act of 2023; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2023 · first_quarter · Q1
The American Rescue Plan, importance of 340B drug pricing program; Provider status for pharmacists; surprise medical billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care; and H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; and FCC's COVID-19 Telehealth Program; support of telehealth policies, including for audio-only telehealth services; within H.R. 5376 impact of pharmaceutical pricing policies on 340B drug discount program; 340B Protect Act, H.R. 4390; and H.R. 2617, the Consolidated Appropriations Act of 2023.
The Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act -collection of data on high Medicaid Hospitals, telehealth expansion; Affordable House Credit Improvement Act of 2021; funding for the HUD HOME program; H.R. 2617, the Consolidated Appropriations Act of 2023; and congressionally directed spending request in the HHS Appropriations bill for capital funding for behavioral health facility.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2022 · fourth_quarter · Q4
Affordable Housing Credit Improvement Act of 2021, Ebola Preparedness and Response Activities; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; the Extending Government Funding and Delivering Emergency Assistance Act - funding for the National Special Pathogen System, Ebola Treatment Centers; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act -collection of data on high Medicaid Hospitals, telehealth expansion; Affordable House Credit Improvement Act of 2021; Senior housing earmark request in the Transportation, Housing, and Urban Development Appropriations Bill; Funding for the HUD HOME program; Inclusion of the JOBS Act in the America COMPETES Act of 2022, H.R. 4521; and H.R. 2617, the Consolidated Appropriations Act of 2023.
COPE Act of 2019, H.R. 1528; American Rescue Plan, importance of 340B drug pricing program; Provider status for pharmacists; surprise medical billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; the Families First Coronavirus Response Act (14k CRA); the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues regarding patient care, Provider Relief Funds; and H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; and FCC's COVID-19 Telehealth Program; support of telehealth policies, including for audio-only telehealth services; Hill-Burton funding for front line safety net hospitals in H.R. 5376; within H.R. 5376 impact of pharmaceutical pricing policies on 340B drug discount program; S. 3799 PREVENT Pandemics Act - social determinants of health provisions; 340B Protect Act, H.R. 4390; and H.R. 2617, the Consolidated Appropriations Act of 2023.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2022 · third_quarter · Q3
Affordable Housing Credit Improvement Act of 2021, Ebola Preparedness and Response Activities; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; The Consolidated Appropriations Act of 2022 and the Extending Government Funding and Delivering Emergency Assistance Act - funding for the National Special Pathogen System, Ebola Treatment Centers; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act -collection of data on high Medicaid Hospitals, telehealth expansion; Affordable House Credit Improvement Act of 2021; Senior housing earmark request in the Transportation, Housing, and Urban Development Appropriations Bill; Funding for the HUD HOME program; Inclusion of the JOBS Act in the America COMPETES Act of 2022, H.R. 4521.
COPE Act of 2019, H.R. 1528; American Rescue Plan, importance of 340B drug pricing program; Provider status for pharmacists; surprise medical billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; The Consolidated Appropriations Act of 2021; the Families First Coronavirus Response Act (14k CRA); the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues regarding patient care, Provider Relief Funds; and H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; and FCC's COVID-19 Telehealth Program; support of telehealth policies, including for audio-only telehealth services; Hill-Burton funding for front line safety net hospitals in H.R. 5376; within H.R. 5376 impact of pharmaceutical pricing policies on 340B drug discount program; S. 3799 PREVENT Pandemics Act - social determinants of health provisions; 340B Protect Act, H.R. 4390.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2022 · second_quarter · Q2
COPE Act of 2019, H.R. 1528; American Rescue Plan, importance of 340B drug pricing program; Provider status for pharmacists; surprise medical billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; The Consolidated Appropriations Act of 2021; the Families First Coronavirus Response Act (14k CRA); the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues regarding patient care, Provider Relief Funds; and H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; and FCC's COVID-19 Telehealth Program; support of telehealth policies, including for audio-only telehealth services; Hill-Burton funding for front line safety net hospitals in H.R. 5376; within H.R. 5376 impact of pharmaceutical pricing policies on 340B drug discount program; S. 3799 PREVENT Pandemics Act - social determinants of health provisions; 340B Protect Act, H.R. 4390.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2022 · first_quarter · Q1
COPE Act of 2019, H.R. 1528; American Rescue Plan, importance of 340B drug pricing program; Provider status for pharmacists; surprise medical billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; The Consolidated Appropriations Act of 2021; the Families First Coronavirus Response Act (14k CRA); the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues regarding patient care, Provider Relief Funds; and H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; and FCC's COVID-19 Telehealth Program; support of telehealth policies, including for audio-only telehealth services; Hill-Burton funding for front line safety net hospitals in H.R. 5376; within H.R. 5376 impact of pharmaceutical pricing policies on 340B drug discount program; S. 3799 PREVENT Pandemics Act - social determinants of health provisions.
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, The Consolidated Appropriations Act of 2022, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion, Provider Relief Funds; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-10 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; H.R. 7292 - The COVID-19 Hospital Forgiveness Act; support of telehealth policies, including for audio-only telehealth services; H.R. 5376 - Build Back Better Act, policies concerning Medicare graduate medical education (GME); H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2021 · fourth_quarter · Q4
Affordable Housing Credit Improvement Act of 2021, Ebola Preparedness and Response Activities; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; The Consolidated Appropriations Act of 2021 and the Extending Government Funding and Delivering Emergency Assistance Act- funding for the National Special Pathogen System, Ebola Treatment Centers; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act -collection of data on high Medicaid Hospitals; Affordable House Credit Improvement Act of 2021.
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, The Consolidated Appropriations Act of 2021, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion, Provider Relief Funds; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-10 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; H.R. 7292 - The COVID-19 Hospital Forgiveness Act; support of telehealth policies, including for audio-only telehealth services; H.R. 5376 - Build Back Better Act, policies concerning Medicare graduate medical education (GME).
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2021 · third_quarter · Q3
COPE Act of 2019, H.R. 1528; American Rescue Plan, importance of 340B drug pricing program; Provider status for pharmacists; surprise medical billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; The Consolidated Appropriations Act of 2021; the Families First Coronavirus Response Act (14k CRA); the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues regarding patient care, Provider Relief Funds; and H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; and FCC's COVID-19 Telehealth Program; support of telehealth policies, including for audio-only telehealth services; Hill-Burton funding for front line safety net hospitals in H.R. 5376; within H.R. 5376 impact of pharmaceutical pricing policies on 340B drug discount program
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, The Consolidated Appropriations Act of 2021, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion, Provider Relief Funds; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-10 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; H.R. 7292 - The COVID-19 Hospital Forgiveness Act; support of telehealth policies, including for audio-only telehealth services.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2021 · second_quarter · Q2
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, The Consolidated Appropriations Act of 2021, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion, Provider Relief Funds; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-10 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; H.R. 7292 - The COVID-19 Hospital Forgiveness Act; support of telehealth policies, including for audio-only telehealth services.
COPE Act of 2019, H.R. 1528; American Rescue Plan, importance of 340B drug pricing program; Provider status for pharmacists; surprise medical billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; The Consolidated Appropriations Act of 2021; the Families First Coronavirus Response Act (14k CRA); the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues regarding patient care, Provider Relief Funds; and H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; and FCC's COVID-19 Telehealth Program; support of telehealth policies, including for audio-only telehealth services.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2021 · first_quarter · Q1
Ebola Preparedness and Response Activities; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; The Consolidated Appropriations Act of 2021 - funding for the National Special Pathogen System, , Ebola Treatment Centers; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act -collection of data on high Medicaid Hospitals.
COPE Act of 2019, H.R. 1528; American Rescue Plan, importance of 340B drug pricing program; Provider status for pharmacists; surprise medical billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; The Consolidated Appropriations Act of 2021; the Families First Coronavirus Response Act (14k CRA); the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues regarding patient care, , Provider Relief Funds; and H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; and FCC's COVID-19 Telehealth Program; support of telehealth policies, including for audio-only telehealth services.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2020 · fourth_quarter · Q4
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; Medicaid Financing Accountability Rule (MFAR) proposed rule; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, The Consolidated Appropriations Act of 2021, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion, Provider Relief Funds; H.R. 266/P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-10 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; H.R. 7292 - The COVID-19 Hospital Forgiveness Act; support of telehealth policies, including for audio-only telehealth services.
Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; the Consolidated Appropriations Act of 2021 - funding for the National Special Pathogen System Ebola Treatment Centers; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - collection of data on high Medicaid Hospitals.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2020 · third_quarter · Q3
COPE Act of 2019, H.R. 1528; importance of 340B drug pricing program; Provider status for pharmacists; surprise medical billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; the Families First Coronavirus Response Act (14k CRA); the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues regarding patient care, preparedness during COVID-19 public health emergency; and H.R. 266/P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; and FCC's COVID-19 Telehealth Program; support of telehealth policies, including for audio-only telehealth services.
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; Medicaid Financing Accountability Rule (MFAR) proposed rule; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion; H.R. 266/P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-10 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; H.R. 7292 - The COVID-19 Hospital Forgiveness Act; support of telehealth policies, including for audio-only telehealth services.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2020 · second_quarter · Q2
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; Medicaid Financing Accountability Rule (MFAR) proposed rule; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion; H.R. 266/P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-10 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; H.R. 7292 - The COVID-19 Hospital Forgiveness Act.
COPE Act of 2019, H.R. 1528; importance of 340B drug pricing program; Provider status for pharmacists; surprise medical billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; the Families First Coronavirus Response Act (14k CRA); the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues regarding patient care, preparedness during COVID-19 public health emergency; and H.R. 266/P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; and FCC's COVID-19 Telehealth Program.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2020 · first_quarter · Q1
Funding for Hospital Preparedness, Ebola Preparedness and Response Activities; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act - funding for the National Special Pathogen System, Hospital Picparedness Program, Ebola Treatment Centers; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - funding for Hospital Preparedness Program during COVID-19 public health emergency.
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicaid Financing Accountability Rule (MFAR) proposed rule; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relict and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion.
THE METROHEALTH SYSTEM via THE METROHEALTH SYSTEM
2020 · first_quarter · RA
Medicare/Medicaid, ACA Implementation, GME, Insurance Reform, Government Grants
Medicare/Medicaid, ACA Implementation, GME, Insurance Reform, Government Grants
Medicare/Medicaid, ACA Implementation, GME, Insurance Reform, Government Grants
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; H.R. 10337, Expanding the Health Care Workforce Act; and H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 1, the One Big Beautiful Bill Act; and H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.
H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8247, the Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; and H.R. 10337, Expanding the Health Care Workforce Act.
Funding for the HUD HOME program; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; and H.R. 1, the One Big Beautiful Bill Act.
H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8247, the Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; and H.R. 10337, Expanding the Health Care Workforce Act.
Funding for the HUD HOME program; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; and H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025.
H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Funding for the HUD HOME program; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; and H.R. 10545, the American Relief Act, 2025.
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies, including for audio-only telehealth services; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies, including for audio-only telehealth services; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.
H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act.
Funding for the HUD HOME program; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; and H.R. 10545, the American Relief Act, 2025.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Funding for the HUD HOME program; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024 and H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024.
H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act.
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies, including for audio-only telehealth services; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; and S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Funding for the HUD HOME program; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024 and H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024.
H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act.
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies, including for audio-only telehealth services; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; and S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies, including for audio-only telehealth services; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024, and H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024 and H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; and H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; support of telehealth policies, including for audio-only telehealth services; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; and H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; COVID-19 regulatory changes in general; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-10 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; support of telehealth policies, including for audio-only telehealth services; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; and H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; COVID-19 regulatory changes in general; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-10 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; support of telehealth policies, including for audio-only telehealth services; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 2617, the Consolidated Appropriations Act of 2023; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion, Provider Relief Funds; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-10 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; support of telehealth policies, including for audio-only telehealth services; H.R. 5376 - Build Back Better Act, policies concerning Medicare graduate medical education (GME); H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; and H.R. 2617, the Consolidated Appropriations Act of 2023.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion, Provider Relief Funds; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-10 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; H.R. 7292 - The COVID-19 Hospital Forgiveness Act; support of telehealth policies, including for audio-only telehealth services; H.R. 5376 - Build Back Better Act, policies concerning Medicare graduate medical education (GME); H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; and H.R. 2617, the Consolidated Appropriations Act of 2023.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, The Consolidated Appropriations Act of 2022, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion, Provider Relief Funds; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-10 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; H.R. 7292 - The COVID-19 Hospital Forgiveness Act; support of telehealth policies, including for audio-only telehealth services; H.R. 5376 - Build Back Better Act, policies concerning Medicare graduate medical education (GME); H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, The Consolidated Appropriations Act of 2022, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion, Provider Relief Funds; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-10 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; H.R. 7292 - The COVID-19 Hospital Forgiveness Act; support of telehealth policies, including for audio-only telehealth services; H.R. 5376 - Build Back Better Act, policies concerning Medicare graduate medical education (GME); H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility.
Affordable Housing Credit Improvement Act of 2021, Ebola Preparedness and Response Activities; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; The Consolidated Appropriations Act of 2022 and the Extending Government Funding and Delivering Emergency Assistance Act - funding for the National Special Pathogen System, Ebola Treatment Centers; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act -collection of data on high Medicaid Hospitals, telehealth expansion; Affordable House Credit Improvement Act of 2021; Senior housing earmark request in the Transportation, Housing, and Urban Development Appropriations Bill; Funding for the HUD HOME program; Inclusion of the JOBS Act in the America COMPETES Act of 2022, H.R. 4521.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Affordable Housing Credit Improvement Act of 2021, Ebola Preparedness and Response Activities; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; The Consolidated Appropriations Act of 2022 and the Extending Government Funding and Delivering Emergency Assistance Act - funding for the National Special Pathogen System, Ebola Treatment Centers; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act -collection of data on high Medicaid Hospitals, telehealth expansion; Affordable House Credit Improvement Act of 2021.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COPE Act of 2019, H.R. 1528; American Rescue Plan, importance of 340B drug pricing program; Provider status for pharmacists; surprise medical billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; The Consolidated Appropriations Act of 2021; the Families First Coronavirus Response Act (14k CRA); the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues regarding patient care, Provider Relief Funds; and H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; and FCC's COVID-19 Telehealth Program; support of telehealth policies, including for audio-only telehealth services; Hill-Burton funding for front line safety net hospitals in H.R. 5376; within H.R. 5376 impact of pharmaceutical pricing policies on 340B drug discount program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Affordable Housing Credit Improvement Act of 2021, Ebola Preparedness and Response Activities; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; The Consolidated Appropriations Act of 2021 - funding for the National Special Pathogen System, Ebola Treatment Centers; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act -collection of data on high Medicaid Hospitals; Affordable House Credit Improvement Act of 2021.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Affordable Housing Credit Improvement Act of 2021, Ebola Preparedness and Response Activities; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; The Consolidated Appropriations Act of 2021 - funding for the National Special Pathogen System, Ebola Treatment Centers; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act -collection of data on high Medicaid Hospitals; Affordable House Credit Improvement Act of 2021.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, The Consolidated Appropriations Act of 2021, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion, Provider Relief Funds; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-10 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; H.R. 7292 - The COVID-19 Hospital Forgiveness Act; support of telehealth policies, including for audio-only telehealth services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COPE Act of 2019, H.R. 1528; importance of 340B drug pricing program; Provider status for pharmacists; surprise medical billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; the Consolidated Appropriations Act of 2021; the Families First Coronavirus Response Act (14k CRA); the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues regarding patient care, Provider Relief Funds; and H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; and FCC's COVID-19 Telehealth Program; support of telehealth policies, including for audio-only telehealth services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Funding for Hospital Preparedness, Ebola Preparedness and Response Activities; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act - funding for the National Special Pathogen System, Hospital Picparedness Program, Ebola Treatment Centers; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - funding for Hospital Preparedness Program during COVID-19 public health emergency; collection of data on high Medicaid Hospitals.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Funding for Hospital Preparedness, Ebola Preparedness and Response Activities; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act - funding for the National Special Pathogen System, Hospital Picparedness Program, Ebola Treatment Centers; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - funding for Hospital Preparedness Program during COVID-19 public health emergency; collection of data on high Medicaid Hospitals.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COPE Act of 2019, H.R. 1528; importance of 340B drug pricing program; surprise medical billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; the Families First Coronavirus Response Act (14k CRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues regarding patient care, preparedness during COVID-19 public health emergency.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE